MyBlueDots

MyBlueDots

Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025

MyBlueDots6 months ago01 mins

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2024 (4Q24), as well as prepared management remarks (in PDF format), on Tuesday, February 11, 2025, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025. To participate via telephone, please register in advance using this link, https

Physical neglect can be as damaging to children’s social development as abuse

MyBlueDots6 months ago01 mins

While physical neglect is understudied compared to physical, sexual or emotional abuse, neglect is just as damaging to children’s social development, a recent study indicates.

For women with multiple sclerosis, mobility takes step backward at menopause

MyBlueDots6 months ago01 mins

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS).

Talquetamab plus teclistamab shows promise in multiple myeloma

MyBlueDots6 months ago01 mins

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 infections than with either therapy alone, according to a study published in the New England Journal of Medicine.

Oral glucose-lowering agents are potential alternatives to insulin for gestational diabetes

MyBlueDots6 months ago01 mins

With respect to the proportion of infants born large for gestational age, treatment of gestational diabetes with metformin and glyburide, if needed, does not meet the criteria for noninferiority versus insulin, according to a study published in the Journal of the American Medical Association.

MyBlueDots

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

MyBlueDots6 months ago01 mins

INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code – 3972058 (Domestic) 312-470-0178 – Access Code – 3972058 (Inte

Kidney cancer study identifies factors for exceptional response to immunotherapy

MyBlueDots6 months ago01 mins

Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when the tumor substantially shrinks for a very long period of time) for some patients with mccRRC, allowing them to live longer with a better quality of life. However, the molecular reasons behind these exceptional responses have not been well defined.

Diet, microbes and fat: A new pathway controlling levels of body fat and cholesterol

MyBlueDots6 months ago01 mins

Beneficial gut microbes and the body work together to fine-tune fat metabolism and cholesterol levels, according to a new preclinical study by investigators from Weill Cornell Medicine and the Boyce Thompson Institute at Cornell University’s Ithaca campus.

Some combinations of long-term health conditions linked to worse quality of life

MyBlueDots6 months ago01 mins

Certain combinations of long-term health conditions are associated with worse quality of life and should be taken into account when assessing patients.

Nonadherence to cancer screening varies by screening type

MyBlueDots6 months ago01 mins

Nonadherence to cancer screening varies by screening type and sex, according to a study published in JAMA Network Open.

Useful _Links

Gene signature of hepatic ferroptosis reveals its pathogenic features

An AI-based classification system for facial pigmented lesions

Engineers create first immunocompetent leukemia device for CAR T immunotherapy screening

Improvements to patient recovery strategies lower long-term opioid usage after colorectal surgery

Proteins important in brain communication have different roles than previously thought

Hidden bias may leave women and older adults underdiagnosed for HIV in Spain

Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025

Physical neglect can be as damaging to children’s social development as abuse

For women with multiple sclerosis, mobility takes step backward at menopause

Talquetamab plus teclistamab shows promise in multiple myeloma

Oral glucose-lowering agents are potential alternatives to insulin for gestational diabetes

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025

Kidney cancer study identifies factors for exceptional response to immunotherapy

Diet, microbes and fat: A new pathway controlling levels of body fat and cholesterol

Some combinations of long-term health conditions linked to worse quality of life

Nonadherence to cancer screening varies by screening type

World News

Useful Links

Health

Business

Entertainment

About Us